India's drug advisory body is considering the future of doorstep medicine delivery, initiated during the Covid pandemic. The All-India Orga...

The Indian government recently banned 156 fixed-dose combination drugs, citing health risks. An expert committee found these combinations l...

FDCs are medicines that combine two or more drugs into a single dosage. The union health and family welfare ministry on Thursday issued a g...

The government is looking to regulate advertisements for anti-diabetes, sex hormone, and oncology drugs by amending the Drugs and Cosmetics...

India's drug regulator has directed state counterparts to provide a list of antibiotic combinations licensed for manufacturing and marketin...

In a boost to conserve vultures in the country, the health ministry has prohibited sale of two veterinary drugs-Ketoprofen and Aceclofenac....

The Drugs Technical Advisory Board (DTAB), India's apex drug advisory body, in its meeting last month was also considering a proposal for e...

A committee had been set up under the chairmanship of CK Kokate, former vice-chancellor of KLE University, Belgaum, to review the safety, e...

Based on the recommendation, the Drugs Controller General of India (DCGI) has sent a draft proposal to the Union Health Ministry for approv...

The ban is effective immediately and may shave off over Rs 1,500 crore from India’s Rs 1.18 lakh crore pharmaceutical industry

ET has viewed parts of the latest ban notifications, which a senior ministry official confirmed would be notified this week.

This report will be sent to the health ministry in the next two weeks, following which the government will decide the fate of these drugs, ...

The FDC were banned by the Centre on the grounds that they involved "risk" to humans and safer alternatives were available.

Companies can make and sell the 349 contested fixed dose combination drugs (FDCs) while Drugs Technical Advisory Board (DTAB) deliberates o...

Delhi HC has declined to vacate the stay earlier granted to certain drug brands banned by the health ministry, and said it would hear all f...

PCMA has opposed the recommendations of the Health Ministry's DTAB demanding ban on use of PET containers for the packaging of pharmaceutic...

In the wake of opposition from industry and medical fraternity to the ban on anti-diabetes drug Pioglitazone, DTAB will review the decision...